MedPath

Evaluation of a Simplified Method for Diagnosis of Sleep Apnea in Children and Adults With Down Syndrome

Completed
Conditions
Down Syndrome
Interventions
Other: Polysomnography
Registration Number
NCT00951730
Lead Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Brief Summary

People with Down syndrome are at increased risk of sleep apnea, not only from obstruction of the upper airway, but also of central origin. According to published data, sleep apnea may occur in at least 40% of children and adults with Down syndrome. Consequences of these sleep apnea are numerous : failure to thrive, cognitive decline, high blood pressure, heart disease, accident due to day sleepiness, fatigue. This condition is treatable in people with Down syndrome, as it is in ordinary people.

Diagnosis of sleep apnea in people with Down syndrome is therefore a major concern. In addition, data regarding age of apparition of this complication are missing, making repeated screening necessary.

Polysomnography is the method of choice for the diagnosis of sleep apnea. Unfortunately, it is time consuming and sleep departments are heavily busy.

Detailed Description

The main objective of our study is to evaluate an easier screening strategy combining questionnaire and overnight recording of few data, compared to polysomnography.

We hope our strategy will permit regular screening for people with Down syndrome, helping us to draw guidelines for the survey of sleep apnea in this population.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
97
Inclusion Criteria
  • Down syndrome
  • Patient (or parents of children) affiliated in a Social Regimen
  • Written consent signed (by parents for the children)
Exclusion Criteria
  • Severe heart failure
  • Insufficient autonomy
  • Diagnosis of insanity, or behavioural problems

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Down syndromePolysomnographyAdult and children with Down syndrome.
Primary Outcome Measures
NameTimeMethod
Apnea / hypopnea events index determined by reading the complete polysomnography (review reference) and apnea / hypopnoea events index determined by the simplified five parameters of the polysomnographyAt 15 days after enroling
Secondary Outcome Measures
NameTimeMethod
Questionnaire on sleepAt inclusion and at the end (18 months)
Psychometric testsAt inclusion and at the end (18 months)

Trial Locations

Locations (3)

CHU de Grenoble

🇫🇷

Grenoble, France

Hospices Civiles de lyon

🇫🇷

Lyon, France

CHU de Saint-Etienne

🇫🇷

Saint-etienne, France

© Copyright 2025. All Rights Reserved by MedPath